DOT1L and leukemia: Recently, more reports have focused on PPIs involving DOT1L epigenetic regulation because this targeted disruption not only ensures that the methylation activity of DOT1L is not affected but also has higher selectivity for leukemia cells than inhibition of DOT1L enzymatic activity.